Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Psychol Med. 2009 Jun 17;40(2):225. doi: 10.1017/S0033291709990213

Table 2.

Dimensions of DSM-IV/CIDI MDE lifetime onset, course, and 12-month persistence and severity by age among NCS-R respondents with MDE

Age Groups
Age
Difference
All ages 18-34 35-49 50-64 65+
Est (se) Est (se) Est (se) Est (se) Est (se) F/χ233

I. Lifetime onset and course
 Mean age of onset 26.2 (0.4) 17.8 (0.2) 25.5 (0.6) 33.1 (0.6) 43.0 (1.6) 696.8*
 Mean number of lifetime episodes 18.6 (1.6) 15.4 (2.3) 18.2 (2.1) 19.7 (3.1) 30.2 (7.9) 3.7
  (n) (1,828) (601) (669) (409) (149)
II. Twelve-month persistence and severity
Mean 12-month duration (in weeks) 27.5 (0.7) 26.8 (1.0) 27.1 (1.3) 28.6 (1.8) 32.4 (2.7) 1.6
Clinically mild (%)1 8.8 (1.0) 8.2 (1.6) 6.8 (1.5) 10.3 (2.0) 21.8 (9.6) 7.2
Clinically severe (%)1 48.0 (1.9) 45.8 (3.0) 53.0 (3.1) 45.8 (5.4) 37.8 (9.6) 8.7*
Severe role impairment (%)2 65.5 (2.3) 62.6 (3.1) 72.2 (3.1) 61.3 (5.7) 56.5 (7.8) 9.9*
Mean days out of role 43.1 (4.2) 28.3 (3.5) 54.4 (9.0) 58.4 (11.5) 18.8 (4.6) 8.3*
  (n) (805) (322) (280) (162) (41)
*

Significant age difference at the .05 level, two-sided test.

1

The percent of cases whose depression was classified either severe or very severe on the self-report version of the Quick Inventory of Depressive Symptomatology (Rush et al., 2003)

2

The percent of cases whose depression-related role impairment was classified either severe or very severe on any dimension of the Sheehan Disability Scales (Leon et al., 1997)

3

Significance was evaluated with an F test for the means (age of onset, mean number of lifetime episodes, mean duration) and a χ2 test for the proportions (the percent of cases classified clinically mild, clinically severe, and having severe role impairment)